Bioventus (BVS) EBITDA Margin (2020 - 2026)
Bioventus' EBITDA Margin was 19.63% in Q2 2026, down 0.97 percentage points from 20.60% a year earlier but up 4.77 percentage points from the prior quarter.
Powered by 
Analysis
Bioventus (BVS) EBITDA Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bioventus' EBITDA Margin was 17.79% through Jun 27, 2026, up 3.05 percentage points year-over-year; for FY2025, it came in at 17.78%, up 11.78 percentage points from FY2024.
- EBITDA Margin has now increased for three consecutive years, with a five-year change of +2.25 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 5.99% in FY2024 (+10.75 pp), -4.75% in FY2023 (+17.08 pp), -21.84% in FY2022 (-32.73 pp) and 10.89% in FY2021 (-4.64 pp).
- Quarterly EBITDA Margin has moved between -88.02% (Q3 2022) and 20.60% (Q2 2025) over five years.
- Compared with a year earlier, EBITDA Margin was higher in six of the last eight quarters, with an average year-over-year change of +5.79 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2023 (a gain of 101.47 percentage points); the worst was Q3 2022 (a drop of 94.88 percentage points).
- Per Business Quant data, BVS's EBITDA Margin in the three quarters before Q2 2026 was 14.85% (Q1 2026), 19.75% (Q4 2025) and 16.34% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.62% |
| 10 | Bioventus | 1.18 Bn | 1.07 Bn | 105.67 Mn | 19.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 19.63% |
| Mar 28, 2026 | 14.85% |
| Dec 31, 2025 | 19.75% |
| Sep 27, 2025 | 16.34% |
| Jun 28, 2025 | 20.60% |
| Mar 29, 2025 | 13.51% |
| Dec 31, 2024 | 13.09% |
| Sep 28, 2024 | 11.46% |
| Jun 29, 2024 | -12.16% |
| Mar 30, 2024 | 12.91% |
| Dec 31, 2023 | 10.06% |
| Sep 30, 2023 | 13.45% |
| Jul 1, 2023 | 15.58% |
| Apr 1, 2023 | -63.49% |
| Dec 31, 2022 | 1.04% |
| Oct 1, 2022 | -88.02% |
| Jul 2, 2022 | 6.47% |
| Apr 2, 2022 | -7.65% |
| Dec 31, 2021 | 6.55% |
| Oct 2, 2021 | 6.86% |
API Access
Bioventus EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();